title: Antimicrobial susceptibility of rapidly growing mycobacteria using the rapid colorimetric method.
abstract: Drug susceptibility testing (DST) of rapidly growing mycobacteria (RGM) are recommended for guiding the antimicrobial therapy. We have evaluated the use of resazurin in Mueller-Hinton medium (MHR) for MIC determination of RGM and compared the results with those obtained with the reference standard broth microdilution in Mueller-Hinton (MH) and with the resazurin microtiter assay (REMA) in 7H9 broth. The MIC of eight drugs: amikacin (AMI), cefoxitin (FOX), ciprofloxacin (CIP), clarithromycin (CLA), doxycycline (DOX), linezolid (LZD), moxifloxacin (MXF) and trimethoprim-sulfamethoxazole (TMP-SMX) were evaluated against 76 RGM (18 species) using three methods (MH, MHR, and REMA) in a 96-well plate format incubated at 37 °C over 3-5 days. Results obtained in the MH plates were interpreted by the appearance of turbidity at the bottom of the well before adding the resazurin. MHR and 7H9-REMA plates were read by visual observation for a change in color from blue to pink. The majority of results were obtained at day 5 for MH and 1 day after for MHR and 7H9-REMA. However, the preliminary experiment on time to positivity results using the reference strain showed that the resazurin can be added to the MH at day 2 to produce the results at day 3, but future studies with large sets of strains are required to confirm this suggestion. A high level of agreement (kappa 1.000-0.884) was obtained between the MH and the MHR. Comparison of results obtained with 7H9-REMA, on the other hand, revealed several discrepancies and a lower level of agreement (kappa 1.000-0.111). The majority of the strains were resistant to DOX and TMP-SMX, and the most active antimicrobials for RGM were AMI and FOX. In the present study, MHR represented an excellent alternative for MIC determination of RGM. The results could be read reliably, more easily, and more quickly than with the classical MH method.
authors.affiliation: Centro de Desenvolvimento Tecnológico (CDTec), Universidade Federal de Pelotas, Pelotas, Brazil, ivynha_@hotmail.com.
authors.forename: I B
authors.initials: IB
authors.lastname: Ramis
authors.forename: M
authors.initials: M
authors.lastname: Cnockaert
authors.forename: A
authors.initials: A
authors.lastname: von Groll
authors.forename: C L
authors.initials: CL
authors.lastname: Nogueira
authors.forename: S C
authors.initials: SC
authors.lastname: Leão
authors.forename: E
authors.initials: E
authors.lastname: Andre
authors.forename: A
authors.initials: A
authors.lastname: Simon
authors.forename: J C
authors.initials: JC
authors.lastname: Palomino
authors.forename: P E A
authors.initials: PE
authors.lastname: da Silva
authors.forename: P
authors.initials: P
authors.lastname: Vandamme
authors.forename: A
authors.initials: A
authors.lastname: Martin
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods*; D009161:Mycobacterium / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D009164:Mycobacterium Infections / Q000382:microbiology; D009170:Nontuberculous Mycobacteria / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Antimicrob Agents Chemother. 2002 Oct;46(10):3164-7
references.pmid: 12234839
references.citation: Indian J Med Microbiol. 2011 Oct-Dec;29(4):343-52
references.pmid: 22120792
references.citation: Minim Invasive Surg. 2011;2011:724635
references.pmid: 22110914
references.citation: Antimicrob Agents Chemother. 2002 Aug;46(8):2720-2
references.pmid: 12121966
references.citation: Future Microbiol. 2011 Sep;6(9):1099-109
references.pmid: 21958147
references.citation: Respiration. 2013;85(4):305-11
references.pmid: 22890130
references.citation: Infect Chemother. 2013 Mar;45(1):85-93
references.pmid: 24265954
references.citation: J Postgrad Med. 2010 Apr-Jun;56(2):76-8
references.pmid: 20622384
references.citation: Antimicrob Agents Chemother. 2003 Nov;47(11):3616-9
references.pmid: 14576129
references.citation: Curr Eye Res. 2010 Mar;35(3):225-9
references.pmid: 20373881
references.citation: New Microbiol. 2012 Jan;35(1):73-6
references.pmid: 22378556
references.citation: J Appl Microbiol. 2009 Aug;107(2):356-67
references.pmid: 19228258
references.citation: Clin Microbiol Rev. 2012 Jul;25(3):545-82
references.pmid: 22763637
references.citation: Int J Tuberc Lung Dis. 2011 Jun;15(6):811-7
references.pmid: 21575304
references.citation: J Clin Microbiol. 2013 Jan;51(1):217-23
references.pmid: 23135941
references.citation: J Microbiol Immunol Infect. 2010 Oct;43(5):401-6
references.pmid: 21075707
references.citation: Drug Resist Updat. 2012 Jun;15(3):149-61
references.pmid: 22525524
references.citation: J Antimicrob Chemother. 2007 Jul;60(1):152-5
references.pmid: 17483147
references.citation: Antimicrob Agents Chemother. 1997 May;41(5):1004-9
references.pmid: 9145860
references.citation: PLoS One. 2013 Dec 30;8(12):e84065
references.pmid: 24386332
references.citation: Lancet Infect Dis. 2013 Feb;13(2):166-74
references.pmid: 23347634
references.citation: Diagn Microbiol Infect Dis. 2004 Jul;49(3):179-82
references.pmid: 15246507